ElMindA is an Israel-US neuro-technology company founded in 2006 with an expert multi-disciplinary team of neuroscientists, physicians, software, and data scientists. Currently, the company holds 58 patents and a proprietary largest database of electrophysiological brain recordings. On 2015 ElMindA was declared by the World Economic Forum as a Technology Pioneer and was ranked among Fast-Company top 50 most innovative companies WW.
Technology: Building upon recent advances in the fields of neuroscience and ICT, ElMindA has developed a game-changing technology called Brain Network Activation (BNATM). BNA combines EEG-technology with big- data analytics and machine learning in order to visualize and quantify brain network functionality. By utilizing state-of-the-art algorithms, such as digital-signal processing, graph theory, clustering analysis, and pattern recognition, ElMindA’s core technology automatically uncovers multidimensional patterns of brain activity that, to date, cannot be identified and visualized with any other available technology. This allows physicians to assess general brain health as well as to monitor rehabilitation processes and responsiveness to treatment for a variety of neurological and mental conditions.
Areas of Focus:
§ Traumatic brain injury
§ Major depression
§ Elderly people
§ Researchers, neuroscience and pharmaceutical companies developing treatments for: dementia, Parkinson’s disease, epilepsy and pain